104 related articles for article (PubMed ID: 34943780)
1. Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats.
Viana LR; Chiocchetti GME; Oroy L; Vieira WF; Busanello ENB; Marques AC; Salgado CM; de Oliveira ALR; Vieira AS; Suarez PS; de Sousa LM; Castelucci BG; Vercesi AE; Consonni SR; Gomes-Marcondes MCC
Cells; 2021 Nov; 10(12):. PubMed ID: 34943780
[TBL] [Abstract][Full Text] [Related]
2. Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway.
Li Y; Chen Y; Liao Y; Huang T; Tang Q; He C; Xu L; Chang H; Li H; Liu Q; Lai D; Xia Q; Zou Z
Apoptosis; 2024 Jun; 29(5-6):663-680. PubMed ID: 38598070
[TBL] [Abstract][Full Text] [Related]
3. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes.
Yano CL; Ventrucci G; Field WN; Tisdale MJ; Gomes-Marcondes MC
BMC Cancer; 2008 Jan; 8():24. PubMed ID: 18226207
[TBL] [Abstract][Full Text] [Related]
5. Development of metabolic and contractile alterations in development of cancer cachexia in female tumor-bearing mice.
Lim S; Deaver JW; Rosa-Caldwell ME; Haynie WS; Morena da Silva F; Cabrera AR; Schrems ER; Saling LW; Jansen LT; Dunlap KR; Wiggs MP; Washington TA; Greene NP
J Appl Physiol (1985); 2022 Jan; 132(1):58-72. PubMed ID: 34762526
[TBL] [Abstract][Full Text] [Related]
6. R-ketorolac ameliorates cancer-associated cachexia and prolongs survival of tumour-bearing mice.
Chrysostomou SE; Eder S; Pototschnig I; Mayer AL; Derler M; Mussbacher M; Schauer S; Zhang D; Yan D; Liu G; Hoefler G; Weichhart T; Vesely PW; Zhang L; Schweiger M
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):562-574. PubMed ID: 38302863
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial fusion and altered beta-oxidation drive muscle wasting in a Drosophila cachexia model.
Dark C; Ali N; Golenkina S; Dhyani V; Blazev R; Parker BL; Murphy KT; Lynch GS; Senapati T; Millard SS; Judge SM; Judge AR; Giri L; Russell SM; Cheng LY
EMBO Rep; 2024 Apr; 25(4):1835-1858. PubMed ID: 38429578
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF).
Mirza KA; Wyke SM; Tisdale MJ
Br J Cancer; 2011 Jun; 105(1):83-8. PubMed ID: 21673682
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous carbon dioxide suppresses skeletal muscle atrophy in a mouse model of oral squamous cell carcinoma.
Sasaki A; Takeda D; Kawai H; Tadokoro Y; Murakami A; Yatagai N; Arimoto S; Nagatsuka H; Akashi M; Hasegawa T
PLoS One; 2024; 19(4):e0302194. PubMed ID: 38630690
[TBL] [Abstract][Full Text] [Related]
10. Effects of cancer-induced cachexia and administration of L-glutathione on the intestinal mucosa in rat.
Sestak SS; da Motta Lima FG; de Oliveira AP; Barateiro LGRP; Vieira-Frez FC; de Souza SRG; Guarnier FA; Perles JVCM; Zanoni JN
Amino Acids; 2024 Apr; 56(1):30. PubMed ID: 38607556
[TBL] [Abstract][Full Text] [Related]
11. Astaxanthin Ameliorates Skeletal Muscle Atrophy in Mice With Cancer Cachexia.
Yu X; Ren P; Yang R; Yue H; Tang Q; Xue C
Nutr Cancer; 2024 Apr; ():1-14. PubMed ID: 38567899
[TBL] [Abstract][Full Text] [Related]
12. A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapy.
Toledo M; Penna F; Oliva F; Luque M; Betancourt A; Marmonti E; López-Soriano FJ; Argilés JM; Busquets S
J Cachexia Sarcopenia Muscle; 2016 Mar; 7(1):48-59. PubMed ID: 27066318
[TBL] [Abstract][Full Text] [Related]
13. The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate.
Russell ST; Siren PM; Siren MJ; Tisdale MJ
Br J Cancer; 2010 Mar; 102(5):833-6. PubMed ID: 20145616
[TBL] [Abstract][Full Text] [Related]
14. Effects of Adjuvant Exercise and Nutrition Therapy on Muscle Fibre Biomechanics in Gastrointestinal Cancer Patients.
Haug M; Schwappacher R; Pollmann C; Ritter P; Michael M; Hermann HJ; Grützmann R; Mittelstädt A; Neurath MF; Zopf Y; Friedrich O
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672689
[TBL] [Abstract][Full Text] [Related]
15. Leucine: a nutrient 'trigger' for muscle anabolism, but what more?
Breen L; Churchward-Venne TA
J Physiol; 2012 May; 590(9):2065-6. PubMed ID: 22548909
[No Abstract] [Full Text] [Related]
16. Withaferin A and Ovarian Cancer Antagonistically Regulate Skeletal Muscle Mass.
Straughn AR; Kelm NQ; Kakar SS
Front Cell Dev Biol; 2021; 9():636498. PubMed ID: 33718372
[TBL] [Abstract][Full Text] [Related]
17. Influence of Amino Acids and Exercise on Muscle Protein Turnover, Particularly in Cancer Cachexia.
Pradhan R; Dieterich W; Natarajan A; Schwappacher R; Reljic D; Herrmann HJ; Neurath MF; Zopf Y
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791998
[TBL] [Abstract][Full Text] [Related]
18. Clinical Relevance of Physical Function Outcomes in Cancer Cachexia.
Caeiro L; Jaramillo Quiroz S; Hegarty JS; Grewe E; Garcia JM; Anderson LJ
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611073
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Muscle Biopsies Reveal Inter- and Intra-Subject Variability in Cancer Cachexia: Paving the Way for Biopsy-Guided Tailored Treatment.
Filis P; Tzavellas NP; Stagikas D; Zachariou C; Lekkas P; Kosmas D; Dounousi E; Sarmas I; Ntzani E; Mauri D; Korompilias A; Simos YV; Tsamis KI; Peschos D
Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473431
[TBL] [Abstract][Full Text] [Related]
20. Narrative Matters: Wasting away and fed up - dietary battles in history.
Whittaker J
Child Adolesc Ment Health; 2024 Feb; 29(1):110-112. PubMed ID: 37897308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
